Getinge AB Aktie
WKN: 889714 / ISIN: SE0000202624
17.07.2015 13:10:00
|
Invitation to the Getinge Group Capital Markets Day on September 2nd 2015
Regulatory News:
We have the pleasure to invite fund managers, analysts and media to the Getinge Group Capital Markets Day 2015. The Capital Markets Day will be held at Aula Medica, Karolinska Institutet in Stockholm, and you will get the opportunity to listen to Alex Myers, CEO & President, Ulf Grunander, CFO, and other members of the Getinge Executive Team.
Program
11.30-12.30 Registration & Lunch 12.30-16.00 Strategic plan including financial targets
Location Erling Persson hall Aula Medica, Karolinska Institutet Nobels väg 6, Solna Stockholm, Sweden
Please register your participation by sending an e-mail to cmd@getinge.com by Friday, August 14th, 2015.
Welcome!
Getinge is a globally leading medical technology company that operates in the areas of surgery, intensive care, infection control, care ergonomics and wound care. Getinge has nearly 16,000 employees in over 40 countries and generates sales of about SEK 27 billion (2014). The Group is divided into three business areas: Medical Systems, Extended Care and Infection Control and operates under the brands of Maquet, ArjoHuntleigh and Getinge.
www.getingegroup.com
This information was brought to you by Cision http://news.cision.com
View source version on businesswire.com: http://www.businesswire.com/news/home/20150717005280/en/

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Getinge ABmehr Nachrichten
27.01.25 |
Ausblick: Getinge AB informiert über die jüngsten Quartalsergebnisse (finanzen.net) | |
13.01.25 |
Erste Schätzungen: Getinge AB präsentiert Bilanzzahlen zum jüngsten Jahresviertel (finanzen.net) | |
17.10.24 |
Ausblick: Getinge AB stellt Zahlen zum jüngsten Quartal vor (finanzen.net) | |
03.10.24 |
Erste Schätzungen: Getinge AB informiert über die jüngsten Quartalsergebnisse (finanzen.net) |
Analysen zu Getinge ABmehr Analysen
Aktien in diesem Artikel
Getinge AB | 20,64 | -1,15% |
|